Palonosetron+Aprepitant+Dexamethasone for highly emetic chemotherapy induced nausea and voimiting
Phase 2
Completed
- Conditions
- ung cancer
- Registration Number
- JPRN-UMIN000004865
- Lead Sponsor
- iigata Lung Cancer Treatment Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 95
Inclusion Criteria
Not provided
Exclusion Criteria
1) Vomiting prior to chemotherapy 2)HEC administration except Day 1. 3)Radiation therapy 4)Contraindication of Dexamethasone 5)Symptomatic brain meta 6)Hypersensitivity for PaIonosetron, Aprepitant, Dexamethasone
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method